Stock Events

Stock Events

Bio-Gate 

€2.80
0
+€0.06+2.19% Wednesday 15:30

Statistics

Day High
2.8
Day Low
2.8
52W High
3.6
52W Low
2.7
Volume
26
Avg. Volume
-
Mkt Cap
28.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2SepExpected
Q2 2025
Next
-0.45
-0.12
0.22
0.55
Expected EPS
N/A
Actual EPS
N/A

Financials

-15.75%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.4MRevenue
-1.17MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
3M
MMM
Mkt Cap89.91B
3M operates in the healthcare segment providing products that overlap with Bio-Gate's antimicrobial solutions.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson offers a range of healthcare products that compete in the antimicrobial space.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including surgical supplies that can compete with Bio-Gate's infection prevention products.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical produces robotic surgical systems that may use antimicrobial technologies similar to those developed by Bio-Gate.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products, competing in areas of infection control similar to Bio-Gate.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation offers medical devices that could incorporate antimicrobial technologies, competing with Bio-Gate.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc manufactures and sells device-based medical therapies, some of which include antimicrobial applications.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories operates in various healthcare segments, potentially competing in antimicrobial product areas.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a broad range of hospital and surgical products, including those for infection prevention.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company offers medical supplies and devices that compete in the infection prevention and control market.

About

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.
Show more...
CEO
Mr. Marc Lloret-Grau
Employees
51
Country
Germany
ISIN
DE000BGAG0J3
WKN
000BGAG0J

Listings

F
DE
BIG.F
XETRA
DE
BIG.XETRA
MU
DE
BIG.MU
STU
DE
BIG.STU

0 Comments

Share your thoughts

FAQ

What is Bio-Gate stock price today?▼
The current price of BIG.XETRA is €2.80 EUR — it has increased by +2.19% in the past 24 hours. Watch Bio-Gate stock price performance more closely on the chart.
What is Bio-Gate stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Bio-Gate stocks are traded under the ticker BIG.XETRA.
What is Bio-Gate market cap?▼
Today Bio-Gate has the market capitalization of 28.54M
When is the next Bio-Gate earnings date?▼
Bio-Gate is going to release the next earnings report on March 03, 2027.
What is Bio-Gate revenue for the last year?▼
Bio-Gate revenue for the last year amounts to 7.4M EUR.
What is Bio-Gate net income for the last year?▼
BIG.XETRA net income for the last year is -1.17M EUR.
How many employees does Bio-Gate have?▼
As of September 04, 2026, the company has 51 employees.
In which sector is Bio-Gate located?▼
Bio-Gate operates in the Materials sector.
When did Bio-Gate complete a stock split?▼
Bio-Gate has not had any recent stock splits.
Where is Bio-Gate headquartered?▼
Bio-Gate is headquartered in Nuremberg, Germany.